Cargando…
AAMP is a binding partner of costimulatory human B7-H3
BACKGROUND: Targeted immunotherapies are of growing interest in the treatment of various cancers. B7 homolog 3 protein (B7-H3), a member of the co-stimulatory/-inhibitory B7-family, exerts immunosuppressive and pro-tumorigenic functions in various cancer types and is under evaluation in ongoing clin...
Autores principales: | Ciprut, Sara, Berberich, Anne, Knoll, Maximilian, Pusch, Stefan, Hoffmann, Dirk, Furkel, Jennifer, Ward Gahlawat, Aoife, Kahlert-Konzelamnn, Lena, Sahm, Felix, Warnken, Uwe, Winter, Martin, Schnölzer, Martina, Pusch, Sonja, von Deimling, Andreas, Abdollahi, Amir, Wick, Wolfgang, Lemke, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341442/ https://www.ncbi.nlm.nih.gov/pubmed/35919070 http://dx.doi.org/10.1093/noajnl/vdac098 |
Ejemplares similares
-
LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
por: Berberich, Anne, et al.
Publicado: (2020) -
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2020) -
Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
por: Friedrich, Mirco, et al.
Publicado: (2022) -
T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
por: Kilian, Michael, et al.
Publicado: (2022) -
AAMP promotes colorectal cancermetastasis by suppressing SMURF2-mediatedubiquitination and degradation of RhoA
por: Wu, Yuhui, et al.
Publicado: (2021)